美国德州大学安德森癌症中心非小细胞肺癌中与治疗反应和耐药相关的分子机制方向博士后

Job Description

Postdoctoral positions are available to study molecular mechanisms associated with therapeutic response and resistance in non-small cell lung cancer (NSCLC) in the laboratory of John V. Heymach, MD, PhD at the University of Texas MD Anderson Cancer Center in Houston, TX. The lab is largely interested in the development of rationale treatment strategies for KRAS/LKB1 mutant NSCLC and EGFR mutant NSCLC with a focus on targetable metabolic adaptations, immunotherapy, and overcoming resistance to targeted therapies. Applicants with experience in any of these areas are encouraged to apply and provide three professional references.
JOB KNOWLEDGE AND SKILLS: 
 Enthusiastic, highly self-motivated candidate, with the ability to function independently 
 A strong background in cell and molecular biology, immunology, or metabolic signaling
 Dedication to basic research, a true “drive”, is important 
 Prior experience with studies involving mice is preferred 
 Command of written and spoken English language
 Prior publication record
EDUCATION/EXPERIENCE 
Applications are invited from qualified individuals, interested in working in a translational research lab; with a PhD and/or MD. Preferred candidate should have less than 2 years of prior postdoctoral experience with background in mouse models studying metabolism, immunology, cancer biology, cell biology or molecular biology and be highly motivated to pursue an independent career in biomedical research.